drugset / Trial / NCT01225510

A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma

NCT01225510

Phase 2 Withdrawn Pfizer
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Angiopoietin-2 (Ang-2) is a protein in the body which destabilizes blood vessels and is important in stimulating tumor blood vessels. There is evidence suggesting that Ang-2 may be important for the growth and progression of Glioblastoma multiforme (GBM). PF- 04856884 (CVX-060) is a compound which binds Ang-2 and prevents its activity. The hypothesis is that PF-04856884 will be safe and effective in patients with recurrent Glioblastoma multiforme (GBM).

Timeline

Start
2011-01
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject CVX-060 Protein / enzyme biologic 15 mg/kg

Indications